Navidea’s Lymph Node Mapping Agent Clears FDA; U.S. Distributor Cardinal Health To Split Revenue
This article was originally published in The Pink Sheet Daily
Executive Summary
Navidea’s Lymphoseek is for use in identifying lymph nodes most likely to harbor cancer in patients with breast cancer and melanoma; the firm hopes for a broader indication in Europe and is working to identify distributors in markets outside the U.S.